Establishment Labs Holdings (ESTA) Total Current Liabilities (2017 - 2026)
Establishment Labs Holdings' (ESTA) quarterly Total Current Liabilities came in at $83.2 million in Q1 2026, up 20.45% year-on-year from $69.0 million in Q1 2025, and up 1.23% quarter-over-quarter from $82.1 million in Q4 2025.
Establishment Labs Holdings (ESTA) Total Current Liabilities (2017 - 2026) Analysis & Trends
Establishment Labs Holdings' Total Current Liabilities history runs 10 years deep, the most recent figure standing at $83.2 million for Q1 2026.
- On a quarterly basis, Total Current Liabilities rose 20.45% year-over-year to $83.2 million in Q1 2026; TTM through Mar 2026 was $83.2 million, a 20.45% increase from a year earlier, with the FY2025 full-year figure at $82.1 million, up 20.31% from the prior year.
- Total Current Liabilities improved to $83.2 million in Q1 2026 per ESTA's latest filing, from $82.1 million in the prior quarter.
- Across five years, Total Current Liabilities topped out at $83.2 million in Q1 2026 and bottomed at $32.4 million in Q3 2022.
- The 5-year median for Total Current Liabilities is $50.3 million (2023), against an average of $54.7 million.
- Across the five-year window, Total Current Liabilities slipped 3.19% in 2024 and jumped 92.74% in 2025, its largest moves.
- Year by year, Total Current Liabilities stood at $39.0 million in 2022, then surged by 46.69% to $57.2 million in 2023, then climbed by 19.47% to $68.3 million in 2024, then gained by 20.31% to $82.1 million in 2025, then rose by 1.23% to $83.2 million in 2026.
- Per Business Quant, the three latest ESTA Total Current Liabilities figures stand at $83.2 million (Q1 2026), $82.1 million (Q4 2025), and $72.0 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Current Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | 18.38 Bn |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | 6.32 Bn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 11.66 Bn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | 4.57 Bn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | 1.41 Bn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | 2.22 Bn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | 8.70 Bn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | 8.53 Bn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | 1.60 Bn |
| 10 | Establishment Labs Holdings | 2.73 Bn | 2.66 Bn | 42.34 Mn | 83.15 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 83.15 Mn |
| Dec 31, 2025 | 82.14 Mn |
| Sep 30, 2025 | 71.98 Mn |
| Jun 30, 2025 | 80.74 Mn |
| Mar 31, 2025 | 69.04 Mn |
| Dec 31, 2024 | 68.28 Mn |
| Sep 30, 2024 | 50.50 Mn |
| Jun 30, 2024 | 41.89 Mn |
| Mar 31, 2024 | 48.02 Mn |
| Dec 31, 2023 | 57.15 Mn |
| Sep 30, 2023 | 50.30 Mn |
| Jun 30, 2023 | 43.27 Mn |
| Mar 31, 2023 | 41.47 Mn |
| Dec 31, 2022 | 38.96 Mn |
| Sep 30, 2022 | 32.38 Mn |
| Jun 30, 2022 | 34.75 Mn |
| Mar 31, 2022 | 36.51 Mn |
| Dec 31, 2021 | 31.89 Mn |
| Sep 30, 2021 | 30.45 Mn |
| Jun 30, 2021 | 27.27 Mn |